Flexible Financing through Series 10 Stock Acquisition Rights
First written in FY2022-Q1. 2 of 4 entries say "Advanced", first in FY2022-Q2. Latest entry: FY2024-Q1.
24 other companies' latest entry also says "Achieved".
- FY2024-Q1AchievedAnnual report
「The company acquired all outstanding Series 10 share acquisition rights on 15 June 2023, and they were cancelled upon expiry of the exercise period.」
The Series 10 share acquisition rights were cancelled on 15 June 2023 following the acquisition of the outstanding rights and expiry of the exercise period, ending the financing scheme. - FY2022-Q3AdvancedAnnual report
「During the third quarter accounting period, the share acquisition rights related to the exercise status of bonds with share acquisition rights subject to an exercise-price adjustment clause and similar instruments were exercised as follows.」
During the quarter, 70 Series 10 share acquisition rights were exercised, 70,000 shares were delivered and ¥267 million was raised. On a cumulative basis, 2,959 rights had been exercised, 2,959,000 shares delivered and ¥11,411 million raised. - FY2022-Q2AdvancedAnnual report
「During the second quarter accounting period, the share acquisition rights related to the exercise status of bonds with share acquisition rights subject to an exercise-price adjustment clause and similar instruments were exercised as follows.」
The Series 10 share acquisition rights were exercised, 2,889,000 treasury shares were delivered and ¥11,143 million was raised. The financing and tradable-share-ratio improvement scheme combined with the treasury share acquisition progressed. - FY2022-Q1First statedAnnual report
「The share acquisition rights issued during the first quarter accounting period were as follows: Series 10 share acquisition rights」
The company issued the Series 10 share acquisition rights approved on 24 May 2021. The number of underlying shares was 6,780,000, the exercise period was from 16 June 2021 to 15 June 2023, the initial exercise price was ¥3,835 per share and the minimum exercise price was ¥3,745. BofA Securities was designated as the prospective allottee. The company presented a scheme combining the acquisition of treasury shares to facilitate flexible financing in line with funding needs and improve the tradable share ratio.